Proinsulin - A pathogenic autoantigen in type 1 diabetes

Autoimmunity Reviews

Volumn 2, Issue 4, 2003, Pages 204-210

  Narendran, Parth ^a   Mannering, Stuart I ^a   Harrison, Leonard C ^a  

^a WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

Autoantigen; Immunity; Insulin; Proinsulin; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; AUTOANTIGEN; C PEPTIDE; EPITOPE; IMMUNOGLOBULIN ANTIBODY; INSULIN ANTIBODY; PROINSULIN;

ANTIGEN EXPRESSION; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CELL DESTRUCTION; CELL SPECIFICITY; CELLULAR IMMUNITY; GENETIC SUSCEPTIBILITY; HUMAN; HYPERGLYCEMIA; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOTHERAPY; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PATHOGENICITY; PREDICTION; REVIEW; RISK ASSESSMENT;

EID: 0038826958     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1568-9972(03)00009-0     Document Type: Review

References (40)

1. Wucherpfennig K.W., Eisenbarth G.S. Type 1 diabetes. Nat Immunol. 2:(9):2001;767-768.
2. Koch R. Die Aetiologie der Tuberculose. Berl Klin Wscht. 19:1882;221.
3. Pugliese A., et al. Self-antigen-presenting cells expressing diabetes-associated autoantigens exist in both thymus and peripheral lymphoid organs. J Clin Invest. 107:(5):2001;555-564.
4. Steiner D.F. New aspects of proinsulin physiology and pathophysiology. J Pediatr Endocrinol Metab. 13:(3):2000;229-239.
5. Ziegler A.G., et al. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study. Diabetes. 48:(3):1999;460-468.
6. Bingley P.J. Interactions of age, islet cell antibodies, insulin autoantibodies, and first-phase insulin response in predicting risk of progression to IDDM in ICA+relatives: the ICARUS data set. Islet Cell Antibody Register Users Study. Diabetes. 45:(12):1996;1720-1728.
7. Yu L., et al. Early expression of antiinsulin autoantibodies in humans and the NOD mouse: evidence for early determination of subsequent diabetes. Proc Natl Acad Sci USA. 97:(4):2000;1701-1706.
8. Keilacker H., et al. Autoantibodies to insulin and to proinsulin in type 1 diabetic patients and in at-risk probands differentiate only little between both antigens. Horm Metab Res. 27:(2):1995;90-94.
9. Bohmer K., et al. Proinsulin autoantibodies are more closely associated with type 1 (insulin-dependent) diabetes mellitus than insulin autoantibodies. Diabetologia. 34:(11):1991;830-834.
10. Vardi P., et al. Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age. Diabetes Care. 11:(9):1988;736-739.
11. Narendran P., et al. Humoral and cellular immune responses to proinsulin in adults with newly diagnosed type 1 diabetes. Diab Metab Res Rev. 19:2003;52-59.
12. Williams A.J., et al. Insulin autoantibodies: more specific than proinsulin autoantibodies for prediction of type 1 diabetes. J Autoimmun. 13:(3):1999;357-363.
13. Hummel M., et al. Proinsulin-specific autoantibodies are relatively infrequent in young offspring with pre-type 1 diabetes. Diabetes Care. 24:(10):2001;1843-1844.
14. Kuglin B., Gries F.A., Kolb H. Evidence of IgG autoantibodies against human proinsulin in patients with IDDM before insulin treatment. Diabetes. 37:(1):1988;130-132.
15. Ellis T., et al. Cellular immune responses against proinsulin: no evidence for enhanced reactivity in individuals with IDDM. Diabetes. 48:(2):1999;299-303.
16. Dubois-LaForgue D., et al. T-cell response to proinsulin and insulin in type 1 and pre-type 1 diabetes. J Clin Immunol. 19:(2):1999;127-134.
17. Schloot N.C., et al. Altered immune response to insulin in newly diagnosed compared to insulin-treated diabetic patients and healthy control subjects. Diabetologia. 40:(5):1997;564-572.
18. Wegmann D.R., Norbury-Glaser M., Daniel D. Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice. Eur J Immunol. 24:(8):1994;1853-1857.
19. Chen W., et al. Evidence that a peptide spanning the B-C junction of proinsulin is an early autoantigen epitope in the pathogenesis of type 1 diabetes. J Immunol. 167:(9):2001;4926-4935.
20. Semana G., et al. T cell autoreactivity to proinsulin epitopes in diabetic patients and healthy subjects. J Autoimmun. 12:(4):1999;259-267.
21. Congia M., et al. T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin. Proc Natl Acad Sci USA. 95:(7):1998;3833-3838.
22. Raju R., Munn S.R., David C.S. T cell recognition of human pre-proinsulin peptides depends on the polymorphism at HLA DQ locus: a study using HLA DQ8 and DQ6 transgenic mice. Hum Immunol. 58:(1):1997;21-29.
23. Rudy G., et al. Similar peptides from two beta cell autoantigens, proinsulin and glutamic acid decarboxylase, stimulate T cells of individuals at risk for insulin-dependent diabetes. Mol Med. 1:(6):1995;625-633.
24. Durinovic-Bello I., Boehm B.O., Ziegler A.G. Predominantly recognized proinsulin T helper cell epitopes in individuals with and without islet cell autoimmunity. J Autoimmun. 18:(1):2002;55-66.
25. Kay T.W., et al. RIP-beta 2-microglobulin transgene expression restores insulitis, but not diabetes, in beta 2-microglobulin null nonobese diabetic mice. J Immunol. 157:(8):1996;3688-3693.
26. Wong F.S., et al. Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library. Nat Med. 5:(9):1999;1026-1031.
27. Daniel D., et al. Epitope specificity, cytokine production profile and diabetogenic activity of insulin-specific T cell clones isolated from NOD mice. Eur J Immunol. 25:(4):1995;1056-1062.
28. Martinez NR, et al. Disabling an integral CTL epitope allows suppression of autoimmune diabetes by intranasal proinsulin peptide. J Clin Invest (in press).
29. Lampeter E.F., McCann S.R., Kolb H. Transfer of diabetes type 1 by bone-marrow transplantation. Lancet. 351:(9102):1998;568-569.
30. Beard M.E., et al. Is type 1 diabetes transmissible by bone marrow allograft? Diabetes Care. 25:(4):2002;799-800.
31. Griffin A.C., et al. Experimental autoimmune insulitis. Induction by T lymphocytes specific for a peptide of proinsulin. Am J Pathol. 147:(3):1995;845-857.
32. Bennett S.T., et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nat Genet. 9:(3):1995;284-292.
33. Pugliese A., et al. The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes. Nat Genet. 15:(3):1997;293-297.
34. French M.B., et al. Transgenic expression of mouse proinsulin II prevents diabetes in nonobese diabetic mice. Diabetes. 46:(1):1997;34-39.
35. Chentoufi A.A., Polychronakos C. Insulin expression levels in the thymus modulate insulin-specific autoreactive T-cell tolerance: the mechanism by which the IDDM2 locus may predispose to diabetes. Diabetes. 51:(5):2002;1383-1390.
36. Harrison L.C., Hafler D.A. Antigen-specific therapy for autoimmune disease. Curr Opin Immunol. 12:(6):2000;704-711.
37. Dosch H., et al. Persistent T cell anergy in human type 1 diabetes. J Immunol. 163:(12):1999;6933-6940.
38. Alleva D.G., et al. A disease-associated cellular immune response in type 1 diabetics to an immunodominant epitope of insulin. J Clin Invest. 107:(2):2001;173-180.
39. Halbout P., et al. T cell response to preproinsulin I and II in the nonobese diabetic mouse. J Immunol. 169:(5):2002;2436-2443.
40. Gottlieb P.A., Eisenbarth G.S. Insulin-specific tolerance in diabetes. Clin Immunol. 102:(1):2002;2-11.